Addiction Medicine Board Exam Preparation & High Yield Question Bank (2020)
The Board Exam Preparation Track is designed for physicians taking the Addiction Medicine Board Exam from the American Board of Preventive Medicine and is aligned with the Board's exam content Blueprint. The Faculty of experienced educators cover 16 key topic areas, with sample exam questions and rationale provided for answers. Test-taking and study tips will be covered. Following recommendations from last year's test-takers, questions on Preventive Medicine will be covered in greater depth this year.
PRICE -- $450 (MEMBERS) ; $600 (NON-MEMBERS) | Total CME credits available: 7.25
The High Yield Question Bank is designed for physicians taking the Addiction Medicine Board Exam from the American Board of Preventive Medicine. The set of over 400 board-style questions has been developed by physicians in the field of addictions and is aligned with the 16 key topic areas of the American Board of Preventive Medicine's exam content Blueprint. This version will offer more demonstration questions on Preventive Medicine as recommended by last year's test-takers. This web-based, on-demand set of questions with correct answers indicated is ideal for self-study and self-paced learning. You may take the quiz multiple times to practice! The question bank was refreshed in 2020 by physicians in the field.
PRICE -- $285 (MEMBERS) ; $400 (NON-MEMBERS) | Total CME credits available: 10
Addiction Medicine Board Exam Preparation (2019)
The Board Exam Preparation Track is designed for those taking the Addiction Medicine Board Exam from the American Board of Preventive Medicine (ABPM). This course helps test-takers focus on high-yield concepts and successful study methods. It's the only Exam Prep with 7 hours of on-demand review of high-yield practice test questions with explanations of the correct answers. Includes 13 Board Exam Prep Track Videos from September 4-7, 2019 in Anaheim and CSAM’s updated Interactive Question Bank.
PRICE -- $595 (CSAM/ASAM MEMBERS); $750 (NON-MEMBERS) | Total CME/CE credits available: 16
The CSAM Review Course in Addiction Medicine 2019 provides an in-depth overview the essentials for treating addicted patients, from basic epidemiology, pharmacology, and neurobiology to the challenge of identifying dependent or at-risk patients across many different treatment settings, from the emergency room to the intensive care unit and to private practice. Participants will come away with practical knowledge that can be applied to real-world situations, as well as help them study for the ABPM Board Exam in Addiction Medicine. Presenters are nationally recognized experts and clinicians with extensive practical experience.The activity consists of 19 recordings of presentations from September 4-7, 2019 in Anaheim, CA.
PRICE -- $595 (CSAM/ASAM MEMBERS); $795 (NON-MEMBERS) | Total CME/CE credits available: 15
Addiction Psychiatry for Addiction Medicine Providers
NEW! This workshop, part of the Addiction Medicine Review Course 2019, is a collaboration between members of the American Academy of Addiction Psychiatry (AAAP) and California Society of Addiction Medicine (CSAM). The goal is to teach clinically relevant addiction psychiatry interventions to non-psychiatric addiction medicine providers. [More]
Practical Office-Based Clinical Management of Patients on Bup-Nal
Real Cases of Buprenorphine-Naloxone Treatment: What To Do And How To Do It? | Soraya Azari, MD, Kenneth Saffier, MD, FASAM and Scott Steiger, MD, FACP, FASAM (Webinar recorded on 2/13/2019) (1 hour)
Fundamentals to Advanced Buprenorphine
This workshop, part of the Addiction Medicine Review Course 2019 focuses on the modern prescribing of buprenorphine for opioid use disorder. Core topics of pharmacology, side effect management, and regulations of buprenorphine treatment are covered. Advances including patient selection, regulatory compliance, low-threshold treatment and new formulations of buprenorphine will move your practice into the state of the art. [More ]
Clinical Approaches to Co-Morbid Pain and Opioid Use Disorder
Transdermal Buprenorphine for Induction of Patients with Co-Morbid Pain | Soraya Azari, MD and Tauheed Zaman, MD (Webinar recorded on 3/13/2019) (1 hour)